A phase III randomized study comparing perioperative nivolumab vs. observation in patients with localized renal cell carcinoma undergoing nephrectomy (PROSPER RCC).

Authors

null

Lauren Christine Harshman

Dana-Farber Cancer Institute, Boston, MA

Lauren Christine Harshman , Maneka Puligandla , Naomi B. Haas , Mohamad Allaf , Charles G. Drake , David F. McDermott , Sabina Signoretti , David Cella , Rajan T Gupta , Rupal Satish Bhatt , Eliezer Mendel Van Allen , Toni K. Choueiri , Primo Lara Jr., Anil Kapoor , Daniel Yick Chin Heng , Brian M. Shuch , Michael A.S. Jewett , Daniel J. George , M Dror Michaelson , Michael Anthony Carducci

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary (Nonprostate) Cancer

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Kidney Cancer

Citation

J Clin Oncol 35, 2017 (suppl; abstr TPS4596)

DOI

10.1200/JCO.2017.35.15_suppl.TPS4596

Abstract #

TPS4596

Poster Bd #

271a

Abstract Disclosures

Similar Posters